Microbubble-based contrast agents with crosslinked and reduced proteinaceous shells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5718884
SERIAL NO

08397065

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention pertains to proteinaceous gas- or gas precursor-containing microbubble contrast agents for use in ultrasound and/or MR imaging, in which the protein matrix is crosslinked by reaction with a bifunctional aldehyde (e.g., a dialdehyde such as glutaraldehyde or an .alpha.,.beta.-unsaturated aldehyde such as acrolein) in an aqueous medium at substantially neutral pH. The contrast agents exhibit improved in vivo and storage stabilities, particularly if the matrix is also reacted with a Schiff's base reducing agent such as a borohydride. Modification of the size distribution of such crosslinked proteinaceous gas-containing contrast agents, e.g. to reduce the mean size of the microbubbles, further enhances their stability and permits preparation of novel contrast agents having a particularly narrow microbubble size distribution.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GE HEALTHCARE AS0485 OSLO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Foss, Per Antonius Oslo, NO 4 107
Ho, slashedgset Anders Oslo, NO 5 478
Hvoslef, Anne Marie S.o slashed.rumsand, NO 1 48
Johansen, John Henrik Oslo, NO 5 65
Klaveness, Jo Oslo, NO 187 4245
Rongved, Pal Nesoddtangen, NO 57 1274

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation